Some salicylaldehyde-derived Baylis-Hillman adducts and 3-(chloromethyl)coumarins have been synthesised and evaluated in vitro for their antisickling activities. The compounds were screened for inhibitory and reversal activity against mutated haemoglobin (HbSS) in red blood cells at four different concentrations (4 mg/mL, 2 mg/mL, 1 mg/mL and 0.5 mg/mL) as a measure of their antisickling potentials. Among the synthesized compounds, 6-chloro-3-(chloromethyl)coumarin 4d showed the highest inhibitory activity (83.75±1.90%), followed by 6-chlorocoumarin-3-methylsulfinic acid 5d (80.90 ±0.91%) and the least was tert-butyl-3-hydroxy-3-(2-hydroxyphenyl)-2-methylenepropanoate 3a (33.33±1.86%). The results obtained from the reversal antisickling experiment showed that the percentage of sickle cells able to revert to the normal biconcave shape was dose dependent. Compound 5d had the highest reversal activity (66.49±1.39%) followed by 6-bromo-3-(chloromethyl)coumarin 4c (59.66±2.95) and 4d (55.50±1.95%) at 4 mg/mL. Compound 4c had higher reversal activity than the standard p-hydroxybenzoic acid at 2 mg/mL, 1 mg/mL and at 0.5 mg/mL. The 3-substituted coumarins 4a-d, and 5d had higher inhibitory antisickling activities than their Baylis-Hillman precursors 3a-d.
Introduction
Sickle cell disease (SCD) is one of the commonest haemoglobinopathies affecting the human population with considerable morbidity and mortality (Ashley-Koch et al., 2000; Makani et al., 2013) . This disease remains a major genetic disorder of the blood affecting tropical areas with its highest prevalence in Sub-Sahara Africa (Imaga et al., 2013) . Sickle cell disease results from a point mutation in the gene coding on the sixth position of β-subunit of the haemoglobin leading to a single amino acid substitution, where valine substitutes glutamic acid (Ashley-Koch et al., 2000) . This condition impairs the tertiary structure of the mutated haemoglobin protein (HbSS) and in turn loses some of its functional properties. Under low oxygen tension, HbSS polymerizes distorting the biconcave-shaped red blood cells into sickled shape and this modification makes the red blood cells fragile and less flexible thereby causing many clinical features that HbSS carriers suffer (Mehanna, 2001; Buchanan et al., 2004) .
Several studies have revealed the antisickling potential of calcium channel blocker, nifedipine (Ma et al., 2012) ; fetal haemoglobin inducers, sodium dimethylbutyrate (Kutlar, 2012) and hydroxyurea (Charache et al., 1995; Steinberg, 1999) . Among these compounds, hydroxyurea is the only agent in clinical use for the treatment of SCD. However, the limitations of hydroxyurea include lower extremity ulceration, xerosis, myelosuppression and possible carcinogenicity (Saraceno et al., 2008; Haywood et al., 2011) .
In recent times, haematopoietic stem cell transplant (HSCT) appears to be the only curative treatment for sickle cell disease available (Bernaudin et al., 2007; Panepinto et al., 2007) . However, lack of suitably matched donors and the chronic use of immunosuppressive drugs with serious side effects have limited the use of HSCT for the treatment of SCD (Bernaudin et al., 2007; Hoban et al., 2016) . Hence, there is need to continue search for other effective therapies that could be used in the management of the disease.
Meanwhile, simple Morita-Baylis-Hillman adducts have become an important class of bioactive compounds with diverse biological activities such as anticancer (Dadwal et al., 2006) , antimalarial (Narender et al., 2005) , molluscidal (Vasconcellos et al., 2006) amongst others. In addition, coumarins form an important pharmacophore in medicinal chemistry and they have been found to exhibit a variety of biological activities usually associated with low toxicity. This has raised considerable interest because of their potential beneficial effects on human health (Hoult and Paya, 1996; Kennedy and Thornes, 1997) . Coumarins possess pharmacological activities such as anti-HIV (Ma et al., 2008) , anticoagulant (Kidane et al., 2004) , antibacterial (Appendino et al., 2004) , antioxidant (Kontogiorgis and Hadjipavlou, 2004) , antimalarial (Yang et al., 1992) , calcium channel blocking activity among other broad spectrum biological activities (He et al., 2007; Asif, 2015) , but are yet to be implicated in the management of sickle cell disease.
In continuation of our interest in exploring the biological applications of coumarins (Olomola et al., 2013; Olomola et al., 2014) , we herein report the antisickling potentials of some salicylaldehyde derived BaylisHillman adducts and their 3-substituted coumarins. Salicyaldehyde, diazabicyclo [2.2.2] octane, tert-butylacrylate, vanillic acid and para-hydroxybenzoic acid, thiourea, glacial acetic acid, concentrated HCl, Phosphate buffered saline (PBS) pH 7.0 were purchased from Sigma Aldrich and used without further purification. Ethylacetate, chloroform, n-hexane and methanol were purchased from BDH chemical, formalin (Fluka), sodium metabisulphite (Hopkins and Williams). The solvents were distilled prior to use. Melting points were determined by open capillaries and uncorrected using a Gallenkamp melting point device. IR spectra were recorded neat on a Pelmer Elmer spectrum 100 FT-IR spectrometer. NMR spectra were recorded on a Bruker 400 MHz AVANCE spectrometer and were referenced using solvent signals (δH: 7.26 ppm for residual CHCl3; δC: 77.0 ppm for CDCl3). Column chromatography was carried out using Merck silica gel 60-120 mesh size as stationary phase and mixture of n-hexane: ethyl acetate as eluant. Antisickling experiments were carried out in the Tissue Culture Laboratory in the Department of Drug Research and Production Unit, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife. Sickle cell blood samples were viewed using a binocular microscope (Feica) and the cells were counted using a manual counter. Incubation of sickled red blood cells was carried out in a thermostated water bath (Tecam). Photomicrograph of prepared slides of HbS blood cells were taken using ScopeImage 9.0 (H1C) camera. (Kaye et al., 2003) . The Baylis-Hillman adducts were further cyclized to 3-(chloromethyl)coumarins 4a-d using acid catalysis (Kaye et al., 2003) . 
Materials and Methods

General
Collection of blood
tert-Butyl
tert-Butyl-3-(5-chloro-2-hydroxyphenyl)-3-hydroxy-2-methylene
Biological evaluation
Compounds 3a-d, 4a-d and 5d were accurately weighed and because they are insoluble in water, were dissolved in 1% Tween 80 to prepare the stock concentration 4 mg/mL of each compound. Lower concentrations such as 2 mg/mL, 1 mg/mL and 0.5 mg/mL were prepared by serial dilution. Portions (0.1 mL) of whole blood samples already collected in EDTA bottles were used for the sickle cell reversal and inhibition experiments.
Sickle cell reversion and inhibitory assay:
The reversal and inhibitory antisickling assays were carried out in vitro according to the method of Egunyomi and co-workers (Egunyomi et al., 2009 
× 100
(1)
The percentage inhibition/reversal was thereafter calculated from the percent sickled cells using the formula:
% inhibition = % sickled cells (C) − % sickled cells (S) % sickled cells in negative (C) × 100
( 2) where C is control and S is sample.
Data treatment
Values were expressed as mean ± standard error for triplicate analysis. The significant differences were analysed using the Student-NewmanKeuls Multiple Comparison test (t-test) and Analysis of Variance (ANOVA), values p < 0.05 were considered to be significant.
Effect on rate of polymerization
HbSS erythrocytes were isolated from the blood samples by centrifugation at 4000 rpm for 5 min. Following careful siphoning of the plasma using a Pasteur pipette, the erythrocytes were repeatedly washed with 0.9% normal saline until a clear supernatant was obtained. The clear supernatant was removed leaving the HbSS erythrocytes as hemolysate for the polymerization experiment. The method of Iwuand co-workers (Iwu et al., 1988) was used for the determination of polymerization rates. 4.4 mL of 2% sodium metabisulphite, 0.5 mL normal saline (0.9% NaCl) and 0.1 mL haemoglobin SS were pipetted into a cuvette, shaken and absorbance is taken at 700 nm (T70 UV/VIS Unicamsectronic Spectrophotometer) 2 minutes interval for 30 minutes. This represents the control. For the test compounds, 4.4 mL 2% NaS205, 0.5 mL of each test compound and 0.1 mL HbSS solution were assayed as above. The rates of polymerization were calculated. Tests were carried out in triplicates and mean values were used for determination of the relative % polymerization. Percentage polymerization rates were plotted against various concentrations using Origin 8.0 software package.
Percentage polymerization was calculated according to Chikezie and coworkers (Chikezie et al., 2010) , thus:
A / = Absorbance of test/control assay at time t mins = Absorbance of control assay at the 30th min
Results and Discussion
Synthesis of Baylis-Hillman adducts and 3-substituted coumarins
Various Baylis-Hillman adducts 3a-d were synthesized following literature methods (Kaye et al., 2003) , using salicylaldehyde derivatives as electrophiles and tert-butyl acrylate as the activated alkene in the presence of diazabicyclo[2.2.2]octane (DABCO). The Baylis-Hillman adducts obtained were cyclized using HCl and AcOH to afford the coumarins 4a-d in very good yields. The Baylis-Hillman adducts 3a-d and 3-chloromethyl(coumarins) 4a-d were characterized and their spectra data are in accordance with literature (Kaye et al., 2003) . In an attempt to synthesize a hydroxyurea analogue, 6-chloro-3-(chloromethyl)coumarin (4d) was treated with thiourea in the hope of obtaining a nucleophilic substitution product but rather spectroscopic evidence suggests the formation of chlorocoumarin-3-sulfinic acid 5d (Scheme 1).
Biological activity
In the inhibitory antisickling assay, incubation of the test compounds with HbSS red blood cell recorded an increase in inhibitory activity which was found to be concentration dependent (Table 1 ). Figure 1 shows typical sodium metabisulphite-induced sickled HbSS red blood cellswhile Figure 2 shows the inhibitory effect of compound 4d on HbSS red blood cells in vitro.
Among the synthesized compounds, 4d showed the highest inhibitory activity (83.75 ± 1.90%), though lower than the standard, vanillic acid (97%) at the same concentration, followed by compound 5d (80.90 ± 0.91%) and the least was 3a (33.33 ± 1.86%). Compound 3c showed its highest inhibitory activity (81.33 ± 5.13%) at a lower concentration, 2 mg/mL, which is comparable to vanillic acid at the same concentration, although vanillic acid gave significantly higher (p< 0.05) inhibitory activity than all the test compounds (96.71 ± 0.91%) at 4mg/mL.. Compound 4c had the red blood cells clumped up at 4 mg/mL (possibly suggesting that the compound may be too toxic to the cells at this concentration) but exhibited significant percentage inhibition (69%) at 2 mg/mL. Meanwhile, compounds 3b and 3d appeared to measure the same percentage inhibition across the concentration gradients as there were no significant differences in the measurements at p< 0.05.
Compounds 3b, 3c, 4a-d and 5d inhibited sodium metabisulphite-induced sickling within the experimental time and it could be that these compounds exhibited inhibitory activities by the inhibition of Ca 2+ -activated K + channel. Under hypoxia condition, this channel had been identified to facilitate the loss of water from the erythrocyte membrane with subsequent increase in the intracellular concentration of HbSS leading to polymerization and its associated vaso-occlusive crises (Archer et al., 2015) .
The reversal activities of the compounds were also found to be concentration dependent and there were significant differences along the concentration gradient for each group (Table 2) . Compound 5d had the highest reversal activity (66.49 ± 1.39%) followed by 4c (59.66 ± 2.95) and 4d (55.50 ± 1.95%) at 4 mg/mL. Compound 4c had higher reversal activity than the standard PHBA at 2 mg/mL, 1 mg/mL and at 0.5 mg/mL. The results obtained from the sickling reversal antisickling experiment showed that the percentage of sickle cells able to revert to the normal biconcave shape was dose dependent. Upon re-oxygenation, sickled red blood cells could be restored to the normal shape (Oder, 2016 DABCO, CHCl3, r.t.; (ii) HCl, AcOH, reflux; (iii) Thiourea, EtOH/H2O (1:1) , r.t. Mag. x400 Olomola et al., 2018 Evaluation of Some Potential Antisickling Compounds.
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It can be deduced from the inhibitory and reversal model that compound 5d was the most active followed by 4d. The three other compounds 4a,4b and 4c were also active. These five compounds were further tested using spectrophotometric method to determine their rate of inhibition of polymerization.The results obtained from rate of polymerization experiment (Figures3a, 3b, 3c and 3d) below showed the effect of 3-substituted coumarins on HbSS hemolysate with a decrease in the sickling rate which was concentration dependent. Within the experimental time t = 30 minutes,there were varying percentages of sickling at different concentrations.4 mg/mL of compound 4d produced a rapid decrease in the rate of polymerization from 34.19 ± 0.1% at time t = 0 to 5.95 ± 0.5% at t = 30 minutes while 4 mg/mL of compound 5d gave 6.87 ± 0.1% and 4c gave a value of 5.86 ± 0.01% at the same concentration compared to the negative control which gave 100 ± 0.2% polymerization with percentage differences in high significance at p< 0.05 (Figure 3a) .4 mg/mL of compound 4d produced a rapid decrease in the rate of polymerization from 34.19 ± 0.1% at time t = 0 to 5.95 ± 0.5% at t = 30 minutes while 4 mg/mL of compound 5d gave 6.87 ± 0.1% and 4c gave a value of 5.86 ± 0.01% at the same concentration compared to the negative control which gave 100 ± 0.2% polymerization with percentage differences in high significance at p< 0.05 ( Figure 3a) . Furthermore, the test compounds reduce the rate of polymerization significantly at 2 mg/mL with 18.94 ± 0.2% for compound 4d, 22.29 ± 1.7% for compound 5d, 26.12% ± 0.00% for compound 4c and 21.55 ± 0.1% for compound 4b (Figure 3b ). The compounds exhibited significant inhibitory antisickling activity at 1 mg/mL and 0.5 mg/mL but at a slower rate (Figures 3c, 3d ).
Conclusion
The inhibitions of the aggregation of deoxyHbS by the synthesized compounds are noteworthy and could serve as antisickling agents with mode of action similar to that of hydroxyurea. The antisickling results showed that the test compounds have comparable activities with the standard drugs, p-hydroxybenzoic acid and vanillic acid. The 3-substituted coumarins 4a-d, and 5d had higher inhibitory antisickling activities than their Baylis-Hillman precursors 3a-d. Thus, this work will be very useful for further studies in terms of effects of the synthesized compounds on the oxygen binding properties of HbSS red blood cells to improve their biological and pharmacological activities. The in vitro antisickling experiments described in this study were carried out in the absence of oxygen. Clinically, sickling occurs significantly under milder conditions with the partial pressure of oxygen of HbSS around 5.5 kPa (Nelson and Cox, 2008) , this would suggest that lower concentrations of the synthesized compounds could be effective in inhibiting sickling in vivo. Also, attempted nucleophilic substitution reactions of 3-(chloromethyl)coumarin substrates with other semicarbazide derivatives is currently being undertaken in our laboratories. 
